Chargement en cours...
Bortezomib Is Cytotoxic to the Human Growth Plate and Permanently Impairs Bone Growth in Young Mice
Bortezomib, a novel proteasome inhibitor approved for the treatment of cancer in adults, has recently been introduced in pediatric clinical trials. Any tissue-specific side effects on bone development have to our knowledge not yet been explored. To address this, we experimentally studied the effects...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3511518/ https://ncbi.nlm.nih.gov/pubmed/23226303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0050523 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|